Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Miele

Showing results (51-60 of 172) with videos related to

Pageof 18
Sort By:
Gastroenterology Research and Practice|June 16, 2015
Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer RiskLuca Miele, Cristina Bosetti, Federica Turati, et al.
Antioxidants (Basel, Switzerland)|January 25, 2025
Gut Microbiota at the Crossroad of Hepatic Oxidative Stress and MASLDFabrizio Termite, Sebastiano Archilei, Francesca D'Ambrosio, et al.
Best Practice & Research. Clinical Gastroenterology|December 7, 2024
Gut microbiome and metabolic dysfunction-associated steatotic liver disease: Pathogenic role and potential for therapeuticsSandra Garcia-Mateo, Debora Rondinella, Francesca Romana Ponziani, et al.
Expert Review of Clinical Pharmacology|March 3, 2018
Treatment of early stage chronic hepatitis C virus infectionFrancesca Romana Ponziani, Luca Miele, Annalisa Tortora, et al.
Molecular Biology Reports|February 22, 2012
A case-control study on the effects of the apolipoprotein E genotypes in nonalcoholic fatty liver diseaseEmma De Feo, Consuelo Cefalo, Dario Arzani, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 18, 2014
Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severityValentina Giorgio, Luca Miele, Luigi Principessa, et al.
Medicine|March 28, 2015
Severe cholestatic hepatitis due to temozolomide: an adverse drug effect to keep in mind. Case report and review of literatureAntonio Grieco, Maria Antonietta Tafuri, Marco Biolato, et al.
Nutrients|December 11, 2019
Mediterranean Diet and NAFLD: What We Know and Questions That Still Need to Be AnsweredMaria Corina Plaz Torres, Alessio Aghemo, Ana Lleo, et al.
International Journal of Molecular Sciences|December 16, 2016
Pathophysiology of Non Alcoholic Fatty Liver DiseaseSalvatore Petta, Amalia Gastaldelli, Eleni Rebelos, et al.
World Journal of Gastroenterology|September 24, 2019
Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantationAlberto Nicoletti, Francesca Romana Ponziani, Marco Biolato, et al.
Pageof 18

Showing results (51-60 of 172) with videos related to

Sort By:
Pageof 18
Gastroenterology Research and Practice|June 16, 2015
Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer RiskLuca Miele, Cristina Bosetti, Federica Turati, et al.
Antioxidants (Basel, Switzerland)|January 25, 2025
Gut Microbiota at the Crossroad of Hepatic Oxidative Stress and MASLDFabrizio Termite, Sebastiano Archilei, Francesca D'Ambrosio, et al.
Best Practice & Research. Clinical Gastroenterology|December 7, 2024
Gut microbiome and metabolic dysfunction-associated steatotic liver disease: Pathogenic role and potential for therapeuticsSandra Garcia-Mateo, Debora Rondinella, Francesca Romana Ponziani, et al.
Expert Review of Clinical Pharmacology|March 3, 2018
Treatment of early stage chronic hepatitis C virus infectionFrancesca Romana Ponziani, Luca Miele, Annalisa Tortora, et al.
Molecular Biology Reports|February 22, 2012
A case-control study on the effects of the apolipoprotein E genotypes in nonalcoholic fatty liver diseaseEmma De Feo, Consuelo Cefalo, Dario Arzani, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 18, 2014
Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severityValentina Giorgio, Luca Miele, Luigi Principessa, et al.
Medicine|March 28, 2015
Severe cholestatic hepatitis due to temozolomide: an adverse drug effect to keep in mind. Case report and review of literatureAntonio Grieco, Maria Antonietta Tafuri, Marco Biolato, et al.
Nutrients|December 11, 2019
Mediterranean Diet and NAFLD: What We Know and Questions That Still Need to Be AnsweredMaria Corina Plaz Torres, Alessio Aghemo, Ana Lleo, et al.
International Journal of Molecular Sciences|December 16, 2016
Pathophysiology of Non Alcoholic Fatty Liver DiseaseSalvatore Petta, Amalia Gastaldelli, Eleni Rebelos, et al.
World Journal of Gastroenterology|September 24, 2019
Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantationAlberto Nicoletti, Francesca Romana Ponziani, Marco Biolato, et al.
Pageof 18